ScholarIQanswers from OpenAlex & ORCID
Douglas J. Schwartzentruber
ResearcherPublications, citations & collaboration network
Douglas J. Schwartzentruber is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Douglas J. Schwartzentruber have?
ScholarIQindexed works
Douglas J. Schwartzentruber has 93 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Douglas J. Schwartzentruber have?
ScholarIQcitation count
Douglas J. Schwartzentruber has 23,221 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Douglas J. Schwartzentruber?
ScholarIQh-index
Douglas J. Schwartzentruber has an h-index of 53 in OpenAlex.
What is the i10-index of Douglas J. Schwartzentruber?
ScholarIQi10-index
Douglas J. Schwartzentruber has an i10-index of 76 in OpenAlex.
What is the OpenAlex record for Douglas J. Schwartzentruber?
ScholarIQopenalex
The OpenAlex for Douglas J. Schwartzentruber is on the source record.
What are the most-cited papers on Douglas J. Schwartzentruber?
ScholarIQmost cited works
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
Mark E. Dudley, John R. Wunderlich, Paul F. Robbins, James Chih‐Hsin Yang, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Richard M. Sherry, Nicholas P. Restifo, Amy M. Hubicki, Michael R. Robinson, Mark Raffeld, Paul H. Duray, Claudia A. Seipp, Linda Rogers-Freezer, Kathleen E. Morton, Sharon Mavroukakis, Donald E. White, Steven A. Rosenberg
A Randomized Trial of Bevacizumab, an Anti–Vascular Endothelial Growth Factor Antibody, for Metastatic Renal Cancer
James Chih‐Hsin Yang, Leah Haworth, Richard M. Sherry, Patrick Hwu, Douglas J. Schwartzentruber, Suzanne L. Topalian, Seth M. Steinberg, Helen X. Chen, Steven A. Rosenberg
Use of Tumor-Infiltrating Lymphocytes and Interleukin-2 in the Immunotherapy of Patients with Metastatic Melanoma
Steven A. Rosenberg, Beverly S. Packard, Paul Aebersold, Diane Solomon, Suzanne L. Topalian, Stephen T. Toy, Paul Simon, Michael T. Lotze, James Chih‐Hsin Yang, Claudia A. Seipp, Colleen Simpson, Charles W. Carter, Steven Bock, Douglas J. Schwartzentruber, John P. Wei, Donald E. White
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma
Steven A. Rosenberg, James Chih‐Hsin Yang, Douglas J. Schwartzentruber, Patrick Hwu, Francesco M. Marincola, Suzanne L. Topalian, Nicholas P. Restifo, Mark E. Dudley, Susan Schwarz, Paul J. Spiess, Maria R. Parkhurst, Yutaka Kawakami, Claudia A. Seipp, Jan Einhorn, Donald E. White
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
Giao Q. Phan, James Chih‐Hsin Yang, Richard M. Sherry, Patrick Hwu, Suzanne L. Topalian, Douglas J. Schwartzentruber, Nicholas P. Restifo, Leah Haworth, Claudia A. Seipp, Linda J. Freezer, Kathleen E. Morton, Sharon Mavroukakis, Paul H. Duray, Seth M. Steinberg, James P. Allison, Thomas A. Davis, Steven A. Rosenberg